| Patents for C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203) |
|---|
| 07/13/2006 | US20060154253 Method for the validated construction of arrays |
| 07/12/2006 | EP1679313A2 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 07/12/2006 | CN1263751C Novel compounds |
| 07/12/2006 | CN1263745C Aryl fused azapolycyclic compounds |
| 07/12/2006 | CN1263720C Triphenylalkene derivatives and their use as selective estrogen receptor modulators |
| 07/11/2006 | US7074805 Especially isoquinolin-5-ylurea derivatives; treating pain, inflammatory thermal hyperalgesia, urinary incontinence and bladder overactivity. |
| 07/11/2006 | US7074800 Quinazoline derivatives as angiogenesis inhibitors |
| 07/11/2006 | US7074788 Antidiabetic agents; liver disorders; cardiovascular disorders; dietetics |
| 07/11/2006 | US7074780 Substituted phenylcyclohexanecarboxamides and their use |
| 07/11/2006 | CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition |
| 07/06/2006 | US20060149074 Method for the production of purified 1,3-substituted imidazolium salts |
| 07/06/2006 | US20060148875 Agent for prophylaxis and treatment of diabetic complications |
| 07/05/2006 | CN1798746A Reverse-turn mimetics and method relating thereto |
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 07/04/2006 | US7071201 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071177 P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 07/04/2006 | US7070630 Primary intermediates for oxidative coloration of hair |
| 07/04/2006 | US7070626 Oxidative coloring agents for keratin fibers |
| 06/29/2006 | US20060142366 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 |
| 06/29/2006 | US20060142365 Benzimidazole compounds and antiviral uses thereof |
| 06/29/2006 | US20060142360 Having a central trivalent nitrogen atom to which is attached either direct or indirectly three ring systems, at least one of which is substituted by a sulfamate group and one by a halogen; steroid sulfatase and aromatase inhibitors |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 06/27/2006 | US7067532 Substituted quinolines as antitumor agents |
| 06/27/2006 | US7067531 Quinolinone derivatives containing imidazole rings is useful as anticarcinogenic agent |
| 06/27/2006 | US7067522 anticarcinogenic, antitumor, antiproliferative agents; focal adhesion kinase (FAK) and cyclin-dependent kinase (CDK) enzyme inhibitors |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067506 Compounds useful for inhibiting Chk1 |
| 06/22/2006 | US20060135584 Novel imidazole alcohol compound, process for producing the same, and surface-treating agent comprising the same |
| 06/22/2006 | US20060135554 Novel compounds |
| 06/21/2006 | EP1671949A2 Substituted phenylamines and pyridinylamines |
| 06/21/2006 | EP0815100B1 Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 06/21/2006 | CN1791410A Methods for treating or preventing an inflammatory or metabolic condition by inhibiting JNK |
| 06/21/2006 | CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 06/14/2006 | EP1669070A2 2-imino-thiazolidine and -oxazolidine derivatives for use as antiinflammatory agents |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/07/2006 | EP1666480A1 Aryl or Heteroaryl Fused Imidazole Compounds as intermediates for Anti-Inflammatory And Analgesic Agents. |
| 06/07/2006 | EP1663965A2 Thrombin receptor antagonists |
| 06/07/2006 | EP1309559B1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | CN1258560C Hot curable epoxy composition in a separated container |
| 06/06/2006 | US7057043 Processes for preparing aminophenylsulfonylureas, and intermediates therefor |
| 06/06/2006 | US7056926 sulfonylurea derivatives, sulfonylthiourea derivatives, sulfonylguanidine derivatives, sulfonylcyanoguanidine derivatives, thioacylsulfonamide derivatives, and acylsulfonamide derivatives; effective for prevention and treatment of cardiovascular diseases, particularly those diseases related to thrombosis |
| 06/06/2006 | CA2199468C 1,2,3,4-tetrahydroquinoxalinedione derivative |
| 06/06/2006 | CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor |
| 06/01/2006 | DE102004056626A1 Substituierte Oxyguanidine Substituted oxyguanidines |
| 05/31/2006 | EP1660455A1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | CN1780619A Derivados de benzoxazol e benzotiazol substitu¿¼dos com (dialopropenil)fenilalquila pesticidas |
| 05/30/2006 | US7053212 Subtype selectivity; cyclohexanecarboxylic acid (4-hydroxy-benzyl)-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amide for example; treating estrogen-related disorders such as sexual disorders, bone disorders; reduction of tamoxifen uterotropic effect |
| 05/30/2006 | US7053106 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 05/30/2006 | US7053105 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 05/30/2006 | US7053104 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 05/25/2006 | US20060111322 Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 05/24/2006 | DE102004055731A1 Single-step preparation of quaternary caustic ammonia, useful in electronic industry, comprises conversion of quaternary ammonium formates/carbonates into quaternary caustic ammonia in the presence of a solvent and a catalyst |
| 05/23/2006 | US7049443 Such as 2-(3-(Acetyl(((5S)-3-(4-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-3 -fluorophenyl)-2-oxo-1,3-oxazolidin-5-yl)meth yl)amino)-1,1-dimethyl-3-oxopropyl)-3,5-dimethylphenyl dihydrogen phosphate; improved bioavailability |
| 05/23/2006 | US7049438 Quinazoline derivatives for treatment of tumours |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/23/2006 | CA2122270C Tri-substituted tetrahydrofuran antifungals |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | CN1256326C 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/16/2006 | US7045517 Triazine compounds |
| 05/16/2006 | US7045514 Therapeutic heterocyclic compounds |
| 05/11/2006 | US20060100246 Synthesis of I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs, by reacting an aryl ketone, an aldehyde and a cyanoacetate with an ammonium salt |
| 05/11/2006 | US20060100227 Pyrimidine derivaties |
| 05/11/2006 | US20060100211 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/10/2006 | EP1654254A1 Antifungal azole derivatives having a fluorovinyl moiety and process for the preparation thereof |
| 05/10/2006 | EP1359892B1 Primary intermediates for oxidative coloration of hair |
| 05/10/2006 | CN1769251A Oligonaphthalene derivatives, and light-emitting element and light-emitting device using oligonaphthalene derivatives |
| 05/10/2006 | CN1255401C Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists |
| 05/10/2006 | CN1255392C Colchinol derivatives as angiogenesis inhibitors |
| 05/10/2006 | CN1255386C Substituted fused heterocyclic compounds |
| 05/09/2006 | US7041834 alkylamination of N-methylcarbazol-5-one at the 6-position in the presence of formaldehyde, a secondary amine, and a desiccant; deamination and coupling of 2-methylimidazole at the 1-position; reaction time less than three hours |
| 05/09/2006 | US7041692 Methods of treating factor VIIa-associated conditions with compounds having an amine nucleus |
| 05/03/2006 | EP1651614A1 Method for the production of purified 1,3-substituted imidazolium salts |
| 05/03/2006 | EP1444224B1 3-substituted oxindole beta-3 agonists |
| 05/03/2006 | EP1444200B1 Azetidinyl diamines useful as ligands of the nociceptin receptor orl-1 |
| 05/03/2006 | CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037916 Antiinflammatory agents; antiarthritic agents; anticholesterol agents; cardiovascular disorders; muscle and skin disorders |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/20/2006 | US20060084690 Isoxazole derivatives |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | CN1761649A Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 |
| 04/19/2006 | CN1252067C Benzazole derivatives and their use as JNK modulators |
| 04/19/2006 | CN1252054C Qinoline derivatives inhibiting effect of growth factors |
| 04/19/2006 | CN1251671C Beta secretase inhibitors |